2030년까지 중남미 근육감소증 치료 시장 전망 - 지역 분석 - 치료 유형(비타민 D 및 칼슘 보충제, 단백질 보충제, 비타민 B12 보충제 등) 및 유통 채널(약국, 소매 채널, 온라인 채널 및 기타)별
임상 시험 단계의 제품은 중남미 근육감소증 치료 시장에 연료를 공급합니다.
근육감소증 치료 시장에서 활동하는 몇몇 주요 업체 근육감소증을 치료하기 위한 약물 개발에 점점 더 집중하고 있습니다. 새로운 근육감소증 치료법은 현재 개발 중이며 임상 시험에서 테스트되고 있습니다. 이러한 제품 중 몇 가지가 아래에 언급되어 있습니다.
임상 개발 중인 근육감소증 약물
회사 이름
중재
조건
임상 시험 Stage
Abbott Nutrition
AN777 함유 의료 식품
경구 영양식
영양실조
근육감소증
PHASE3 < br>
Nutricia Research
식이 보조제: Bolus ONS A
식이 보조제: Bolus ONS B
식이 보조제: Bolus ONS C
식이 보조제 보충제: Bolus ONS D
근육감소증
PHASE1
Novartis Pharmaceuticals
약물: Bimagrumab
근육감소증
PHASE2
McMaster University
행동: 단계 감소
근육감소증
PHASE1
Metabolic Technologies Inc.
식이 보조제 : 위약
약물: HMB Plus 비타민 D
행동: 비운동
행동: 운동
근육감소증
PHASE1
Merck Sharp & Dohme LLC
약물: 비교기 MK-077
약물: 위약 비교
육감소증
PHASE2
Immunotec Inc.
건강보조식품: 면역
건강보조식품: 카세인
노화와 근육감소증
PHASE2
양리준
병용 제품: 3개월 집중 중재
근육감소증
PHASE4
Regeneron Pharmaceuticals
약물: REGN1033(SAR391786)
< br>약물: 위약
사코페니아
PHASE2
출처: 회사 웹사이트 및 The Insight Partners Analysis
따라서, 다양한 임상 개발 단계는 근육감소증 치료 시장 성장에 중요한 기회를 제공합니다.
남미 및 중앙아메리카 근육감소증 치료 시장 개요
남미 및 중앙아메리카의 근육감소증 치료 시장은 브라질, 아르헨티나 및 나머지 중남미 지역으로 구분됩니다. 노인 인구의 증가와 비타민 결핍의 급증으로 인해 중남미 지역의 근육감소증 치료 시장이 성장하고 있습니다.
2018년 국립위생감시청(ANVISA)이 식이보충제에 대한 새로운 규정을 도입하면서 브라질에서 새로운 브랜드의 진출이 더 쉬워졌습니다. 더욱이 이는 기존 브랜드가 국내에서 번성하고 혁신하는 데 도움이 되었습니다. 국립 의학 도서관(National Library of Medicine)에 발표된 연구에 따르면, 브라질에서는 노인 인구가 빠르게 증가하고 있으며, 이로 인해 노년기와 관련된 만성 질환의 유병률이 증가하고 있습니다. 브라질 노인 인구의 전반적인 근육감소증 유병률은 2020년 약 20.0%였습니다. 국립 보건원(National Institute of Health)에서 발표한 기사에 따르면 2022년 브라질 노인 여성의 근육감소증 가능성 유병률은 42.0%입니다.
2030년까지의 중남미 근육감소증 치료 시장 수익 및 예측(미화 백만 달러)
중남미 근육감소증 치료 시장 세분화
남중미 근육감소증 치료 시장은 치료 유형, 유통 채널, 국가로 분류됩니다.
치료 유형에 따라 중남미 근육감소증 치료 시장은 비타민 D 및 칼슘 보충제, 단백질 보충제, 비타민 B12 보충제 등으로 분류됩니다. 비타민 D 및 칼슘 보충제 부문은 2022년 중남미 근육감소증 치료 시장에서 가장 큰 점유율을 차지했습니다.
유통 채널 측면에서 중남미 근육감소증 치료 시장은 약국, 소매 채널, 온라인으로 분류됩니다. 채널 및 기타. 약국 부문은 2022년 가장 큰 중남미 근육감소증 치료 시장 점유율을 차지했습니다.
국가별로 중남미 근육감소증 치료 시장은 브라질, 아르헨티나, 나머지 중남미 지역으로 분류됩니다. 브라질은 2022년 중남미 근육감소증 치료 시장 점유율을 장악했습니다.
Abbott Laboratories, Bayer AG, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp 및 GSK Plc는 일부입니다. 중남미 근육감소증 치료 시장을 선도하는 기업입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
4.1 South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - South & Central America Market Analysis
5.1 South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020- 2030
5.2 South & Central America Sarcopenia Treatment Market Forecast and Analysis
6. South & Central America Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Sarcopenia Treatment Market - Country Analysis
8.1 South & Central America
8.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 Rest of South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Nestle Health Science SA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novartis AG
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Pfizer Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Sanofi SA
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Amway Corp
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 GSK Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. South & Central America Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 14. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 15. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. South & Central America Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. South & Central America Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. South & Central America Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. South & Central America Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. South & Central America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Nestle Health Science SA
4. Novartis AG
5. Pfizer Inc
6. Sanofi SA
7. Amway Corp
8. GSK Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.